Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001631 · ClinicalTrials.gov registry record · Phase 2
Study of Blood Flow in Heart Muscle
A Phase 2 study, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- Completed
- Registry status
- Phase 2
- Development phase
- 249
- Enrollment target
NCT00001631 is a Phase 2 study that has completed, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 249 participants.
The verdict
NCT00001631, a Phase 2 study, has completed, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 249 participants
- Enrollment target
Study Summary
Blood flows to areas of the heart providing oxygen and fuel to the pumping muscle. Occasionally the arteries providing the fuel can become blocked. This occurs in coronary artery disease. Magnetic resonance imaging (MRI) can be used to evaluate the blood flow to different areas of the heart muscle. In this study magnetic resonance imaging will be compared to other diagnostic tests (radionucleotide perfusion studies) capable of measuring blood flow to heart muscle.
Interventions
- PROCEDURE Magnetic resonance imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 249 participants |
| Start Date | 1997-08 |
| Est. Completion | 2003-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00001631
The ClinicalTrials.gov registry entry for NCT00001631 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 249 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Heart, Lung, and Blood Institute (NHLBI), which has 501 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Magnetic resonance imaging is the first listed.
NCT00001631 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00001631 about?
NCT00001631 is a clinical study titled "Study of Blood Flow in Heart Muscle". Blood flows to areas of the heart providing oxygen and fuel to the pumping muscle. Occasionally the arteries providing the fuel can become blocked. This occurs in coronary artery disease. Magnetic resonance imaging (MRI) can be used to evaluate the blood flow to different areas of the heart muscle....
What is the current status of trial NCT00001631?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 249 participants. The study started on 1997-08. Estimated completion is 2003-01.
What interventions are being tested in trial NCT00001631?
The interventions under investigation include: Magnetic resonance imaging (PROCEDURE).
Who is sponsoring clinical trial NCT00001631?
This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.